Two studies of tumor tissues from gastric cancer patients found that the level of ISG15 mRNA expression was significantly higher in irinotecan-sensitive tumors than that in the irinotecan-resistant tumors [135, 162]. This evidence concerns the gene ISG15 and neoplasm.